WallStSmart
IGC

India Globalization Capital Inc

AMEX: IGC · HEALTHCARE · BIOTECHNOLOGY

$0.30
+3.45% today

Updated 2026-06-03

Market cap
$28.63M
P/E ratio
P/S ratio
25.88x
EPS (TTM)
$-0.06
Dividend yield
52W range
$0 – $1
Volume
1.4M

India Globalization Capital Inc (IGC) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20072008200920102011201220132014201520162017201820192020202120222023202420252026
Revenue$-765000.00$2.19M$35.34M$17.90M$4.07M$4.20M$8.03M$2.27M$7.68M$6.37M$580372.00$2.19M$5.12M$4.07M$898000.00$397000.00$911000.00$1.34M$1.27M$1.19M
Revenue growth (YoY)+386.0%+1515.1%-49.4%-77.2%+3.1%+91.2%-71.7%+237.9%-17.1%-90.9%+277.9%+133.3%-20.4%-77.9%-55.8%+129.5%+47.6%-5.5%-6.7%
Cost of revenue$1.84M$28.05M$15.67M$3.92M$4.82M$6.50M$1.89M$7.10M$5.52M$362135.00$2.11M$4.98M$3.96M$1.25M$203000.00$1.07M$612000.00$652000.00$834000.00
Gross profit$-765000.00$346525.00$7.29M$2.23M$159264.00$-618000.00$1.53M$381596.00$579689.00$843294.00$218237.00$81524.00$132000.00$115000.00$-349000.00$194000.00$-158000.00$733000.00$619000.00$352000.00
Gross margin100.0%15.8%20.6%12.4%3.9%-14.7%19.1%16.8%7.5%13.2%37.6%3.7%2.6%2.8%-38.9%48.9%-17.3%54.5%48.7%29.7%
R&D$0.00$0.00$0.00$0.00$137000.00$114000.00$137000.00$1.26M$1.01M$929000.00$2.33M$3.46M$3.77M$3.65M$5.19M
SG&A$765047.00$341000.00$4.98M$5.61M$7.28M$4.70M$3.04M$2.18M$4.14M$2.70M$1.88M$1.73M$3.52M$5.97M$7.91M$13.29M$8.55M$6.76M$4.41M$4.10M
Operating income$-765047.00$5000.00$3.81M$-3.99M$-7.91M$-7.51M$-2.48M$-2.53M$-4.34M$-2.91M$-2.05M$-1.79M$-4.64M$-6.86M$-8.72M$-15.43M$-11.57M$-9.80M$-7.45M$-10.20M
Operating margin100.0%0.2%10.8%-22.3%-194.1%-178.9%-30.9%-111.2%-56.5%-45.6%-353.9%-81.6%-90.8%-168.6%-971.5%-3886.1%-1270.1%-728.5%-585.8%-860.3%
EBITDA$2.41M$4.37M$4.36M$-5.74M$-14.73M$-5.77M$-1.54M$-2.04M$-3.61M$-1.89M$-1.22M$-1.74M$-4.58M$-6.72M$-8.33M$-14.37M$-10.85M$-9.16M$-6.98M$-9.88M
EBITDA margin-314.6%199.5%12.3%-32.0%-361.5%-137.3%-19.2%-89.7%-47.0%-29.7%-210.0%-79.2%-89.6%-165.0%-928.0%-3618.4%-1190.9%-681.1%-549.3%-833.0%
EBIT$2.38M$5000.00$3.48M$-6.34M$-15.51M$-6.76M$-2.21M$-2.75M$-4.39M$-2.62M$-1.62M$-1.76M$-4.64M$-6.86M$-8.81M$-15.02M$-11.51M$-9.80M$-7.45M$-10.20M
Interest expense$103916.00$1.94B$1.75M$1.22M$1.40M$984021.00$419436.00$291520.00$286332.00$213928.00$223464.00$30742.00$0.00$0.00$0.00$412000.00$65000.00
Income tax$784858.00$-76000.00$1.53M$-3.11M$4.10M$172828.00$-365000.00$35461.00$5157.00$579.00$14431.00$464.00$2000.00$782000.00$169000.00$-412000.00$-65000.00$3.35M
Effective tax rate34.1%1.4%151.5%39.4%-25.4%-2.3%13.9%-1.2%-0.1%-0.0%-0.8%-0.0%-0.0%-12.0%-2.0%2.7%0.6%-34.6%0.0%0.0%
Net income$1.52M$-5.21M$-522000.00$-4.79M$-20.24M$-7.75M$-2.25M$-3.02M$-4.61M$-2.81M$-1.87M$-1.79M$-4.10M$-7.32M$-8.81M$-15.02M$-11.51M$-13.00M$-7.12M$-6.55M
Net income growth (YoY)-443.5%+90.0%-817.4%-322.7%+61.7%+70.9%-34.2%-52.6%+39.1%+33.5%+4.3%-129.4%-78.5%-20.5%-70.4%+23.4%-13.0%+45.2%+8.0%
Profit margin-198.4%-238.3%-1.5%-26.8%-496.8%-184.6%-28.0%-133.0%-60.1%-44.1%-321.7%-81.4%-80.1%-179.6%-981.2%-3782.4%-1263.0%-966.5%-560.3%-552.1%

Frequently asked questions

What is India Globalization Capital Inc's revenue?

India Globalization Capital Inc's trailing twelve-month revenue is $1.11M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is IGC?

In its most recent fiscal year, IGC ran a gross margin of 29.68%, an operating margin of -860.29%, and a net margin of -552.11%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does IGC generate?

IGC produced $-6.11M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is IGC's balance sheet healthy?

IGC holds $207000.00 in cash and equivalents against $131000.00 in long-term debt, on $6.12M of shareholder equity. Cash on hand exceeds long-term debt, so the balance sheet adds little financial risk to the thesis.